Back
World11 May 2026 at 03:30 am
Kiran Mazumdar-Shaw names niece Claire as successor, targets semaglutide push from FY28; debt cut to $1.1 billion
Quick Take
Biocon's Executive Chairperson, Kiran Mazumdar-Shaw, outlined a five-year leadership transition with her niece, Claire Mazumdar, as successor. The company anticipates a strong FY27 launch calendar, particularly in the second half, with a focus on ...
Why It Matters
Global events reshape the risk-reward calculus for cross-border investment. What happens in one region increasingly determines outcomes everywhere else.